(Q41071705)

26 September 2017

1 reference

title

Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins (English)

1 reference

26 September 2017

1 reference

Alaupovic P

1

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

26 September 2017

published in

Methods in Enzymology

1 reference

26 September 2017

volume

263

1 reference

26 September 2017

page(s)

32-60

1 reference

Colloidal solution. The globulins

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Separation of Proteins. Part III. Globulins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The Apparent Formation of Euglobulin from Pseudo-Globulin and a Suggestion as to the Relationship between these two Proteins in Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies on the Cholesterol Content of Normal Human Plasma. Part II: The Attraction of the Proteins of Plasma for Sterols

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A method for localization and determination of serum lipids after electrophoretical separation on filter paper

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Lipoprotein patterns of serum obtained by zone electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

An investigation of serum lipids and lipoproteins by paper electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The ultracentrifugal protein sedimentation diagram of normal human, cow and horse serum

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The antigenic similarity of human low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Immunologic studies of human high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies on the antigenicity of beta- and alpha-lipoproteins of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Blood Lipids and Human Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Lipoproteins in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Protein-lipid relationships in human plasma. I. In normal individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Electrophoretic and ultracentrifugal analysis of serum lipoproteins of normal, nephrotic and hypertensive persons

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The lipoproteins of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

1 reference

7 January 2021

N-terminal residues of serum lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

C-and N-terminal amino acids of human serum lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Immunochemical studies on human plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies on the immunochemistry of human low density lipoproteins utilizing an hemagglutination technique

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The immunochemical hetero-geneity of human plasma beta-lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

N-terminal amino acid and lipid composition of lipoproteins from chyle and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

On having no beta-lipoprotein. A syndrome comprising a-beta-lipoproteinaemia, acanthocytosis, and steatorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Heterogeneity in protein subunits of human serum high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Isolation and characterization of polypeptides of human serum lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies of the composition and structure of plasma lipoproteins. C- and N-terminal amino acids of the two nonidentical polypeptides of human plasma apolipoprotein A

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Characterization and immunoassay of apolipoprotein D

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A new protein from human plasma lipoproteins: isolation and partial characterization of apolipoprotein G

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein A-IV: a Protein Occurring in Human Mesenteric Lymph Chylomicrons and Free in Plasma. Isolation and Quantification

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Isolation and characterization of two threonine-poor apolipoproteins of human plasma high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Separation and partial characterization of new apoproteins from human plasma high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The mysteries of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Lipoprotein(a). A unique risk factor for atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein genetic variation and human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A molecular theory of lipid-protein interactions in the plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Identification of a novel in-frame translational stop codon in human intestine apoB mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Structure-function relationships of the complement components

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Binding of β2-glycoprotein-I to Intralipid: Determination of the dissociation constant

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

In vivo metabolism of apolipoprotein S in humans. Comparison with apolipoprotein A-I metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein J: structure and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Role of Specific Glycopeptides of Human Serum Lipoproteins in the Activation of Lipoprotein Lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A protein cofactor of lecithin:cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The Interaction of Heparin with an Apoprotein of Human Very Low Density Lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Metabolic heterogeneity in very low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

High-density lipoprotein turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

The lipoprotein A-II (LP-A-II) family in normolipidemic subjects and patients with Apo-AI deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Composition of plasma ApoA-I-containing lipoprotein particles in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Selective isolation of human plasma low-density lipoprotein particles containing apolipoproteins B and E by use of a monoclonal antibody to apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Identification and partial characterization of discrete apolipoprotein A-containing lipoprotein particles secreted by human hepatoma cell line HepG2

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Isolation of high density lipoproteins from rat intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein A-I containing lipoproteins in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Serum lipid and apolipoprotein levels in a Nigerian population sample

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Contribution of endosomes to intrahepatic distribution of apolipoprotein B and apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoproteins, dyslipoproteinaemia and premature coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Quantitative and qualitative changes of apolipoprotein AI-containing lipoproteins in patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Lipid and apolipoprotein compositions of two species of ApoA-I containing lipoproteins in young girls with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Identification of apoB-containing lipoprotein families in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

Is it time to measure apolipoprotein B?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963004-3

7 January 2021

10.1016/S0076-6879(96)63004-3

Identifiers

DOI

1 reference

release_klpzrhi5lrghhgwvhrgzfkyiiq

26 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/klpzrhi5lrghhgwvhrgzfkyiiq

24 November 2022

mapped directly with Wikidata item

1 reference